
    
      OBJECTIVES:

      I. To evaluate the effect of MC5-A on pain symptoms both immediately and over time.

      II. To evaluate the effect of Calmare therapy on other non-pain symptoms. III. To evaluate
      the effect of MC5-A on daily opioid and other pain medication use.

      OUTLINE: Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy
      over 30 minutes once daily for 10 days. After completion of study treatment, patients are
      followed up for 3 months.
    
  